Clinical trial
11C Topotecan PET Imaging
NCT00253461 · Case Comprehensive Cancer Center, Other · Terminated
Key facts
| NCT number | NCT00253461 |
|---|---|
| Title | 11C Topotecan PET Imaging |
| Official title | Positron Emission Tomography Using 11C Topotecan in Predicting Response to Treatment in Patients With Brain Metastases Due to Ovarian, Small Cell Lung, or Other Cancer |
| Lead sponsor | Case Comprehensive Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Terminated |
| Phase | Early Phase 1 |
| Study type | Interventional |
| Conditions | Lung Cancer, Metastatic Cancer, Ovarian Cancer, Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Procedure, Radiation |
| Interventions | computed tomography, positron emission tomography, 11C topotecan, fludeoxyglucose F 18 |
| Enrollment | 7 |
| Start date | Dec 1, 2004 |
| Primary completion | Nov 1, 2009 |
| Completion | Nov 1, 2009 |
| First posted | Nov 15, 2005 |
| Last update posted | Mar 20, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: